Mission
The Middle East Cystic Fibrosis Association (MECFA) is a nonprofit organization dedicated to enhancing health outcomes for cystic fibrosis (CF) patients across the Middle East, North Africa, and Central Asia. MECFA focuses on improving access to essential therapies, early diagnosis, training healthcare professionals, and advocating for patient rights regarding CF care. Given that only 1 in 10 CF patients in the region currently have access to specialized care, MECFA aims to bridge this gap through strategic partnerships, training, and community outreach.
Basic Information
Tax-Exempt
Founded in
2020
EIN
85-1096028
Total Assets
$43.46 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 2 of 2 goals
At a Glance
Giving Breath Campaign
A campaign raising funds to provide nebulizers to CF patients in need.
MECFA CF Academy
Educational program for clinicians aimed at improving CF patient outcomes.
Access to Essential Drugs
Advocacy efforts to gain patient access to essential CF therapies in developing countries.
Impact Stats
10 units each of Iontophoresis and sweat chloride analyzers
Amount of equipment donated
Diagnostic Equipment Donation
MECFA donated 10 Iontophoresis units and 10 sweat chloride analyzers along with supplies for 10,000 tests to hospitals in various countries.
1 (Jordan)
Countries involved in MAP pilot
Access Program Launch
In 2022, MECFA launched the MECFA Access Program (MAP) to provide essential CF therapies at reduced prices.
Impact Reports
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
50
44
/100
Program Expense Ratio
92.63%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.138
18
/20
Working Capital Ratio
0.1208
2
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2023
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 244K | 80.04% |
| Program Services | 60.84K | 19.96% |
| Investment Income | 6 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 304.8K | 100.00% |
Related Nonprofits
International Society for Respiratory Protection
Health Associations
Pulmonary Disease Prevention
Society for Pediatric Dermatology Inc.
Health Associations
Pulmonary Disease PreventionBreathe California of the Bay Area Golden Gate and Central Coast
Health Associations
Pulmonary Disease PreventionAmerican Liver Foundation
Health Associations
Pulmonary Disease PreventionAssociation of Professors of Dermatology
Health Associations
Pulmonary Disease Prevention